Future approaches to clearing the latent human immunodeficiency virus reservoir: Beyond latency reversal
Background: While combined antiretroviral therapy (cART) allows near-normal life expectancy for people living with human immunodeficiency virus (HIV), it is unable to cure the infection and so life long treatment is required. Objectives: The main barrier to curing HIV is the latent reservoir of cell...
Saved in:
Main Author: | Alexander M.L. Hayes (Author) |
---|---|
Format: | Book |
Published: |
AOSIS,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PP 1.10 - 00069 Isotretinoin enhances IL-15 mediated HIV latency reversal and reduces the inducible latent reservoir
by: J. Howard, et al.
Published: (2022) -
Hormonal control of HIV-1 latency by estrogen imparts gender-specific restrictions on the latent reservoir
by: J. Karn, et al.
Published: (2019) -
Approaches to discover latency-reversing agents
Published: (2015) -
Reactivation capacity by latency reversing agents ex vivo correlates with the size of the HIV-1 reservoir
by: Gilles Darcis, et al.
Published: (2016) -
The efficacy and tolerability of latency-reversing agents in reactivating the HIV-1 reservoir in clinical studies: a systematic review
by: Quinten Debrabander, et al.
Published: (2023)